IJR News — today's news from every side
+140 Tom Gallagher The split into five tiger-cat species should help target conservation better, but it also shows how fragile these small populations really are.
Dr. David Crean Book Guides Biopharma Leaders on Commercialization x/david-crean — Sep 18, 2026 A new book, Dual Fluency: Bridging Science, Capital, and Governance in Life Sciences by Dr. David H. Crean, offers a practical blueprint for biopharma to move from discovery to commercialization by focusing on three core translations—Data to Capital, Discovery to Deal, and Bench to Boardroom—along with Capital Stack Optimization. Aimed at scientist-founders, pre-commercial CEOs, BD executives, and investors, the work promises actionable risk-reduction insights and will be available on Amazon and major bookstores through Cardiff Advisory LLC. +5 Jared Kim This book seems helpful for scientist founders who struggle turning research into actual funding and governance plans.